Co-Authors
This is a "connection" page, showing publications co-authored by ARGUN AKCAKANAT and DAVID SANGHYUN HONG.
Connection Strength
0.192
-
Targeting translation initiation in breast cancer. Translation (Austin). 2014; 2(1):e28968.
Score: 0.120
-
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation. Breast Cancer Res. 2019 07 05; 21(1):78.
Score: 0.043
-
Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial. Clin Cancer Res. 2013 Oct 01; 19(19):5474-84.
Score: 0.029